Health · 2 views
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine .
AI Summary
A clinical trial published in the New England Journal of Medicine examined continuous glucose monitors (CGMs) in adults with type 2 diabetes who do not use insulin. Participants who wore CGMs spent roughly five additional hours each day within their target blood‑sugar range compared with those receiving routine care. The study also reported that nearly twice as many CGM users achieved an A1c level below 7%, a common treatment goal. Researchers suggest the technology could markedly improve diabetes management for millions of Americans.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Wearing headphones during surgery may reduce nausea and vomiting afterwardContinue reading
- Adult ADHD; Encouraging Advance Care Planning; Hospital Closures in the U.S.Continue reading
- Brain injury care guidelines for first responders releasedContinue reading
- When cancer turns critical, the patient isn't the only one sufferingContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow